Patents
Patents for C07D 231 - Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings (25,550)
05/2003
05/27/2003US6569969 Forming a mixture of one or more monomers, at least one free radical source and a control agent and subjecting mixture to polymerization conditions
05/27/2003US6569886 Parasiticides
05/27/2003US6569885 Cyclic AMP-specific phosphodiesterase inhibitors
05/22/2003WO2003042208A1 Pyrazole derivatives as psychopharmaceuticals
05/22/2003WO2003042183A1 Process for production of pyrazole compounds
05/22/2003WO2003042164A1 Aryl aniline beta-2 adrenergic receptor agonists
05/22/2003WO2003042160A1 Aryl aniline beta-2 adrenergic receptor agonists
05/22/2003WO2003042147A1 Dihalogenpropene compounds, method for the production thereof, agents containing said compounds and the use thereof as pest control agents
05/22/2003WO2003041502A1 Pesticidal 1-(2-fluorethyl)-4-arylpyrazole derivatives
05/22/2003WO2003007883A3 Acylsemicarbazides as cyclin dependent kinase inhibitors useful as anti-cancer and anti-proliferative agents
05/22/2003WO2000037429A3 INHIBITORS OF α4β1 MEDIATED CELL ADHESION
05/22/2003US20030097004 3,4-Di-substituted cyclobutene-1,2-diones as CXC chemokine receptor antagonists
05/22/2003US20030096853 Processes for the preparation of 1,5-diarylpyrazoles
05/22/2003US20030096844 Cannabinoid receptor ligands
05/22/2003US20030096826 Inhibitors of interleukin-1 beta converting enzyme and other cysteine proteases in the ICE family
05/22/2003US20030096825 Antiviral activity; treatment of HIV and AIDS
05/22/2003CA2467115A1 Process for production of pyrazole compounds
05/22/2003CA2467081A1 Pyrazole derivatives as psychopharmaceuticals
05/22/2003CA2466962A1 Aryl aniline beta-2 adrenergic receptor agonists
05/21/2003EP1311478A1 Novel thiourea compounds and the pharmaceutical compositions containing the same
05/21/2003EP1115701B1 Arylsulfonanilide ureas
05/21/2003CN1419547A Compounds exhibiting thrombopoietin receptor agaonism
05/21/2003CN1419546A 4,5-dihydro-1h-pyrazole derivatives having cbi-antagonistic activity
05/21/2003CN1419537A Insecticidal anthranilamides
05/21/2003CN1419534A Diphenyl ether compounds useful in therapie
05/21/2003CN1418870A 3,4-dibidro-1H-anphthalene derivatives used as high selectivity inhibitor of cyclooxygenase-2
05/21/2003CN1109030C Processes for preparing intermediate product used in method of diastereoselective syntheses of nucleosides
05/20/2003US6566533 Reacting aza-heterocyclic compounds (indoles and carbazoles) with alkyl- or aryl-halides in the presence of carbon dioxide and alkali carbonate
05/20/2003US6566377 Have utility as, inter alia, hypoglycemic, and anti-obesity agents.
05/20/2003US6566307 α,α′-substituted n-alkyl-3-alkenylbenzoyl-pyrazol-derivatives
05/20/2003CA2123606C New substituted pyrazolylpyrazoles, processes for their preparation, as well as intermediates, and their use as herbicides
05/20/2003CA2110693C Amino acid derivative anticonvulsant
05/15/2003WO2003040112A1 Substituted diphenyl heterocycles useful for treating hcv infection
05/15/2003WO2003040105A1 Polymorphous form of rimonabant, preparation method and pharmaceutical compositions containing same
05/15/2003WO2003040096A2 N, n'-substituted-1,3-diamino-2-hydroxypropane derivatives
05/15/2003WO2003040086A1 5-amidino-2-hydroxybenzenesulfonamide derivatives, medicinal compositions containing the same, medicinal use thereof and intermediates in the production thereof
05/15/2003WO2003039549A2 Selective antibacterial agents
05/15/2003WO2003039529A1 Selective antibacterial agents
05/15/2003WO2003031435A8 Pyrazole derivatives as glycine transporter inhibitors
05/15/2003US20030092740 Anticoagulants
05/15/2003CA2466284A1 N, n'-substituted-1,3-diamino-2-hydroxypropane derivatives
05/15/2003CA2465189A1 Substituted diphenyl heterocycles useful for treating hcv infection
05/15/2003CA2464763A1 5-amidino-2-hydroxybenzenesulfonamide derivatives, medicinal compositions containing the same, medicinal use thereof and intermediates in the production thereof
05/15/2003CA2464757A1 Selective antibacterial agents
05/15/2003CA2464145A1 Polymorphic form of rimonabant, method for preparing it and pharmaceutical compositions containing it
05/14/2003EP1310485A1 Pyrrole derivatives
05/14/2003EP1309591A2 Substituted pyrazoles
05/14/2003EP1309565A1 Heterocyclic mutilin esters and their use as antibacterials
05/14/2003EP1309561A1 1h-pyrazol derivatives, method for producing them and their use as nitrification inhibitors
05/14/2003EP1309328A1 Cox-2 inhibitors and the prevention of the side effects of radiation therapy
05/14/2003EP1309315A2 Rapidly disintegrating oral formulation of a cyclooxygenase-2 inhibitor
05/14/2003CN1418212A Method for producing 7-(phrazole-3-yl) benzoxazoles
05/14/2003CN1418191A Novel thiourea derivatives and the pharmaceutical compositions containing thd same
05/13/2003US6562856 Pyrazolyl benzyl ether deriviatives having a fluoromethoxy group and the use thereof as pesticides
05/13/2003US6562817 Suppressants of the IgE production
05/08/2003WO2003037874A1 An efficient synthesis of 5-heteroatom-containing-pyrazoles
05/08/2003WO2003037853A1 Substituted thioacetamides
05/08/2003WO2003037847A1 Benzamide derivatives as antagonists of orexin receptors
05/08/2003WO2003037352A1 1-phenyl-5-n-heterocyclyl-pyrazoles as cyclooxygenase inhibitors for the treatment of inflammation associated disorders
05/08/2003WO2003037332A1 Phenyl substituted 5-membered nitrogen containing heterocycles for the treatment of obesity
05/08/2003WO2003037274A2 Pyrazole-amides and-sulfonamides
05/08/2003US20030087950 New alpha-amino acid sulphonyl compounds
05/08/2003US20030087933 Use of central cannabinoid receptor antagonist for preparing medicines designed to facilitate smoking cessation
05/08/2003US20030087899 Administering a stress-activated protein kinase inhibitor, particularly a fused pyrrolocarbazole compound.
05/08/2003US20030087151 Low melting point
05/08/2003CA2464944A1 An efficient synthesis of 5-heteroatom-containing-pyrazoles
05/08/2003CA2463441A1 Phenyl substituted 5-membered nitrogen containing heterocycles for the treatment of obesity
05/08/2003CA2462206A1 Substituted thioacetamides
05/07/2003EP1308438A1 3-substituted urea derivatives and medicinal use thereof
05/07/2003EP1308161A1 5-N-heterocyclyl-1-(4-sulfonyl-phenyl)-1H-pyrazole derivatives with cyclooxygenase 2 (COX-2) inhibiting activity for the treatment of inflammatory diseases
05/07/2003EP1307184A2 Drugs for incontinence
05/07/2003EP0889863B1 Surface modified carbonate materials
05/07/2003EP0749433B1 (4,4-difluorobut-3-enylthio)-substituted heterocyclic or carbocyclic ring compounds having pesticidal activity
05/07/2003CN1107673C Pesticidal 1-aryl-3-iminopyrazoles
05/07/2003CN1107672C Intermediate for preparing pyrazole derivatives
05/07/2003CN1107671C Imide derivatives
05/06/2003US6559102 Applying one or more 3-aryl-pyrazole compounds to undesirable plants, fungi and/or their habitat
05/06/2003US6559100 2-benzoyl-cyclohexane-1,3-diones
05/02/2003EP1306368A2 3,4-dihydro-1H-naphtalene derivatives as a highly selective cyclooxygenase-2 inhibitor
05/02/2003EP1305304A1 Carboxamide compounds and their use as antagonists of a human 11cby receptor
05/02/2003EP1305292A1 Biphenyl carboxamides
05/02/2003EP1194408B1 $g(A)-$g(a)'-SUBSTITUTED N-ALKYL-3-ALKENYLBENZOYL-PYRAZOL-DERIVATIVES
05/02/2003EP1139758B1 Fungicide mixture
05/02/2003EP0966452B1 Process for preparing sulphurous 2-chloro-3-(4,5-dihydroisoxazol-3-yl)-benzoic acids
05/02/2003EP0946514B1 Method for producing n-substituted 3-hydroxypyrazoles
05/02/2003EP0918761B1 Certain amido- and amino-substituted benzylamine derivatives; a new class of neuropeptite y1 specific ligands
05/02/2003CA2410364A1 5-heterocyclo-pyrazoles
05/01/2003WO2003035643A1 Pyrazolyl-substituted heterocycles and their use as phytosanitary products
05/01/2003WO2003035625A1 Substituted indazole compounds for the treatment of inflammation
05/01/2003WO2003035620A1 Bicyclic compound
05/01/2003WO2003035609A1 Zwitterionic imides
05/01/2003WO2003035602A1 Lipid modulators
05/01/2003WO2003035064A1 Pyrazolidinone compounds as ligands of the prostaglandin ep2 and/or ep4 receptors
05/01/2003WO2003035005A2 Heteroindanes: a new class of potent cannabimimetic ligands
05/01/2003US20030083505 Benzenedicarboxylic acid derivatives
05/01/2003US20030083351 Antihypoxic agents
05/01/2003US20030083346 Hydroxy substituted fused naphthyl-azoles and fused indeno-azoles and their use for the treatment of glaucoma
05/01/2003CA2463290A1 Zwitterionic imides
05/01/2003CA2460680A1 Substituted indazole compounds for the treatment of inflammation
04/2003
04/30/2003CN1414849A Carboxylic acid amides, medicaments containing these compounds and the use and preparation thereof